The Patent Finder

Antibodies Against Human CSF-1R and Uses Thereof

Hoffmann-La Roche Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 12/962,445, filed Dec 7, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,499,625Antibodies Against Human CSF-1R and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In force
High confidence
US 9,499,626Antibodies Against Human CSF-1R and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In force
High confidence
US 9,663,580Antibodies Against Human CSF-1R and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In force
High confidence
US 9,879,085Antibodies Against Human CSF-1R and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In force
High confidence
US 10,072,087Antibodies Against Human CSF-1R and Uses Thereof
In force
 · Medium confidence
Hoffmann-La Roche Inc.In force
Medium confidence
US 10,077,314Antibodies Against Human CSF-1R and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In force
High confidence
US 10,287,358Antibodies Against Human CSF-1R and Uses Thereof
In force
 · Medium confidence
Hoffmann-La Roche Inc.In force
Medium confidence
US 9,499,624Antibodies Against Human CSF-1R and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In force
High confidence
US 8,999,327Antibodies Against Human CSF-1R and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In force
High confidence
Application 16/362,962Antibodies Against Human CSF-1R and Uses Thereof
Abandoned
Abandoned Feb 1, 2020
Hoffmann-La Roche Inc.AbandonedAbandoned Feb 1, 2020
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
9 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited